Literature DB >> 1891214

Long-term efficacy of repeat argon laser trabeculoplasty.

R M Feldman1, L J Katz, G L Spaeth, J A Crapotta, I A Fahmy, M A Ali.   

Abstract

The role of repeat argon laser trabeculoplasty (RALT) in the management of open-angle glaucoma is controversial. To determine the long-term efficacy of RALT, the authors reviewed case records of 44 patients (50 eyes) who received RALT for uncontrolled glaucoma at the Wills Eye Hospital before 1986. Success was defined as a 3 mmHg or greater decrease in intraocular pressure (IOP) to less than 22 mmHg, and no further surgical intervention. By life table analysis, RALT was successful in 35% of eyes at 6 months, in 21% at 12 months, in 11% at 24 months, and in 5% at 48 months. Thirty-three percent of eyes in which primary ALT was successful for 1 year were successful 12 months after RALT. Complications included IOP spikes in 12%. In conclusion, RALT was generally not effective for long-term control of open-angle glaucoma, but may be useful as a temporizing measure. However, this use of RALT must be weighed against the risks of complications and the additional progression of disease before more definitive surgical intervention.

Entities:  

Mesh:

Year:  1991        PMID: 1891214     DOI: 10.1016/s0161-6420(91)32176-6

Source DB:  PubMed          Journal:  Ophthalmology        ISSN: 0161-6420            Impact factor:   12.079


  11 in total

1.  Baseline IOP predicts selective laser trabeculoplasty success at 1 year post-treatment: results from a randomised clinical trial.

Authors:  W G Hodge; K F Damji; W Rock; R Buhrmann; A M Bovell; Y Pan
Journal:  Br J Ophthalmol       Date:  2005-09       Impact factor: 4.638

2.  Intraocular pressure reduction after initial failure of selective laser trabeculoplasty (SLT).

Authors:  Marcelo Ayala
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2013-11-21       Impact factor: 3.117

3.  Micropulse diode laser trabeculoplasty (MDLT): A phase II clinical study with 12 months follow-up.

Authors:  Antonio Maria Fea; Alex Bosone; Teresa Rolle; Beatrice Brogliatti; Federico Maria Grignolo
Journal:  Clin Ophthalmol       Date:  2008-06

4.  Update on laser trabeculoplasty.

Authors:  Fathi El Sayyad; Magdi Helal
Journal:  Middle East Afr J Ophthalmol       Date:  2009-07

5.  The effect of argon laser trabeculoplasty on the blood-aqueous barrier and intraocular pressure in human glaucomatous eyes treated with diclofenac 0.1%.

Authors:  M Diestelhorst; D Thull; G K Krieglstein
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1995-09       Impact factor: 3.117

6.  Pneumatic trabeculoplasty vs latanoprost as adjunctive therapy to timolol in primary open-angle glaucoma or ocular hypertension.

Authors:  M G Uva; A Longo; M Reibaldi
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2009-02-27       Impact factor: 3.117

7.  Clinical options for the reduction of elevated intraocular pressure.

Authors:  Laura Crawley; Sohaib M Zamir; Maria F Cordeiro; Li Guo
Journal:  Ophthalmol Eye Dis       Date:  2012-04-30

8.  Lasers in primary open angle glaucoma.

Authors:  Ramanjit Sihota
Journal:  Indian J Ophthalmol       Date:  2011-01       Impact factor: 1.848

Review 9.  Noninvasive glaucoma procedures: current options and future innovations.

Authors:  Ahmed M Abdelrahman
Journal:  Middle East Afr J Ophthalmol       Date:  2015 Jan-Mar

10.  Repeat selective laser trabeculoplasty can be effective in eyes with initial modest response.

Authors:  Albert S Khouri; James Lin; Tamara L Berezina; Barry Maltzman; Robert D Fechtner
Journal:  Middle East Afr J Ophthalmol       Date:  2014 Jul-Sep
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.